30 related articles for article (PubMed ID: 33045974)
1. A Light-Driven Therapy of Pancreatic Adenocarcinoma Using Gold Nanorods-Based Nanocarriers for Co-Delivery of Doxorubicin and siRNA.
Yin F; Yang C; Wang Q; Zeng S; Hu R; Lin G; Tian J; Hu S; Lan RF; Yoon HS; Lu F; Wang K; Yong KT
Theranostics; 2015; 5(8):818-33. PubMed ID: 26000055
[TBL] [Abstract][Full Text] [Related]
2. Silencing of Carboxypeptidase E expression inhibits proliferation and invasion of Panc-1 pancreatic cancer cells.
Lou H; Loh YP
F1000Res; 2021; 10():489. PubMed ID: 35528956
[No Abstract] [Full Text] [Related]
3. VHH212 nanobody targeting the hypoxia-inducible factor 1α suppresses angiogenesis and potentiates gemcitabine therapy in pancreatic cancer
Kang G; Hu M; Ren H; Wang J; Cheng X; Li R; Yuan B; Balan Y; Bai Z; Huang H
Cancer Biol Med; 2021 Apr; 18(3):772-87. PubMed ID: 33830713
[TBL] [Abstract][Full Text] [Related]
4. Variants of bcl-2 specific siRNA for silencing antiapoptotic bcl-2 in pancreatic cancer.
Ocker M; Neureiter D; Lueders M; Zopf S; Ganslmayer M; Hahn EG; Herold C; Schuppan D
Gut; 2005 Sep; 54(9):1298-308. PubMed ID: 16099798
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumorigenic effects of naive and TLR4-primed adipose-derived mesenchymal stem cells on pancreatic ductal adenocarcinoma cells.
Kaçaroğlu D; Yaylacı S; Gurbuz N
Cancer Med; 2024 Jan; 13(2):e6964. PubMed ID: 38379331
[TBL] [Abstract][Full Text] [Related]
6. Characterisation of the cell and molecular biological effect of peptide-based daunorubicin conjugates developed for targeting pancreatic adenocarcinoma (PANC-1) cell line.
Szász Z; Enyedi KN; Takács A; Fekete N; Mező G; Kőhidai L; Lajkó E
Biomed Pharmacother; 2024 Apr; 173():116293. PubMed ID: 38430628
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic Cancer: From Genome Discovery to PRECISION-Panc.
Dreyer SB; Jamieson NB; Morton JP; Sansom OJ; Biankin AV; Chang DK
Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):5-8. PubMed ID: 31522943
[No Abstract] [Full Text] [Related]
8. Author Correction: Differential roles of highly expressed PFKFB4 in colon adenocarcinoma patients.
Gu X; Dai X; Huang Y; Zhang Y; Dong L; Gao C; Wang F
Sci Rep; 2023 Dec; 13(1):21842. PubMed ID: 38071368
[No Abstract] [Full Text] [Related]
9. Altered Gemcitabine and Nab-paclitaxel Scheduling Improves Therapeutic Efficacy Compared with Standard Concurrent Treatment in Preclinical Models of Pancreatic Cancer.
Wolfe AR; Robb R; Hegazi A; Abushahin L; Yang L; Shyu DL; Trevino JG; Cruz-Monserrate Z; Jacob JR; Palanichamy K; Chakravarti A; Williams TM
Clin Cancer Res; 2021 Jan; 27(2):554-565. PubMed ID: 33087331
[TBL] [Abstract][Full Text] [Related]
10. Targeting interleukin-17 receptor B enhances gemcitabine sensitivity through downregulation of mucins in pancreatic cancer.
Tsai LH; Hsu KW; Chiang CM; Yang HJ; Liu YH; Yang SF; Peng PH; Cheng WC; Wu HH
Sci Rep; 2020 Oct; 10(1):17817. PubMed ID: 33082357
[TBL] [Abstract][Full Text] [Related]
11. Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy.
Mirzaei S; Gholami MH; Ang HL; Hashemi F; Zarrabi A; Zabolian A; Hushmandi K; Delfi M; Khan H; Ashrafizadeh M; Sethi G; Kumar AP
Cells; 2021 Nov; 10(12):. PubMed ID: 34943856
[TBL] [Abstract][Full Text] [Related]
12. Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma.
Tuerhong A; Xu J; Shi S; Tan Z; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Liang C
Cell Mol Life Sci; 2021 Jul; 78(14):5505-5526. PubMed ID: 34131808
[TBL] [Abstract][Full Text] [Related]
13. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
14. Effects of alphavbeta6 gene silencing by RNA interference in PANC-1 pancreatic carcinoma cells.
Niu W; Liu X; Zhang Z; Xu K; Chen R; Liu E; Wang J; Peng C; Niu J
Anticancer Res; 2010 Jan; 30(1):135-42. PubMed ID: 20150628
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-1 up-regulates the expression of Toll-like receptor 4 in pancreatic cancer cells under hypoxic conditions.
Fan P; Zhang JJ; Wang B; Wu HQ; Zhou SX; Wang CY; Zhang JH; Tian Y; Wu HS
Pancreatology; 2012; 12(2):170-8. PubMed ID: 22487528
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells.
Minchenko OH; Tsuchihara K; Minchenko DO; Bikfalvi A; Esumi H
World J Gastroenterol; 2014 Oct; 20(38):13705-17. PubMed ID: 25320508
[TBL] [Abstract][Full Text] [Related]
17. Molecular Subtyping and Precision Medicine for Pancreatic Cancer.
Froeling FEM; Casolino R; Pea A; Biankin AV; Chang DK
J Clin Med; 2021 Jan; 10(1):. PubMed ID: 33406790
[TBL] [Abstract][Full Text] [Related]
18. Studying the Anti-Tumor Effects of siRNA Gene Silencing of Some Metabolic Genes in Pancreatic Ductal Adenocarcinoma.
Al Hanjori AS; Alshaer W; Al-Anati B; Wehaibi S; Zihlif M
Curr Mol Pharmacol; 2021 Oct; 14(4):604-619. PubMed ID: 33045974
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
